July 14, 2022

FDA Allows US Providers to Buy Bayer Foreign-Labeled Contrast Media

Due to iodinated contrast media shortages caused by a temporary shutdown of a GE Healthcare plant in Shanghai, the U.S. Food and Drug Administration Bayer® to import a limited quantity of foreign-labeled ULTRAVIST® (iopromide).

Per Bayer’s , this imported stock is manufactured at the same site as ULTRAVIST (iopromide) intended for the U.S. market; but is not labeled with current FDA-approved labeling.

Providers are directed to the full for ULTRAVIST (iopromide) to ensure the USPI are followed. Get more details from and the .

For more information, contact Gloria Romanelli, 新澳门六合彩官网® (新澳门六合彩官网®) Senior Director, Legislative and Regulatory Relations and Legal Counsel, Quality and Safety.

The 新澳门六合彩官网 also encourages members to visit the 新澳门六合彩官网 Contrast Media Shortage Page.